TWI255726B - A suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge - Google Patents

A suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge

Info

Publication number
TWI255726B
TWI255726B TW091101272A TW91101272A TWI255726B TW I255726 B TWI255726 B TW I255726B TW 091101272 A TW091101272 A TW 091101272A TW 91101272 A TW91101272 A TW 91101272A TW I255726 B TWI255726 B TW I255726B
Authority
TW
Taiwan
Prior art keywords
suspension
carrier
coating
thrombin
fibrinogen
Prior art date
Application number
TW091101272A
Other languages
English (en)
Inventor
Alfred Schaufler
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Application granted granted Critical
Publication of TWI255726B publication Critical patent/TWI255726B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/36—Surgical swabs, e.g. for absorbency or packing body cavities during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/044—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/046—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H1/00—Macromolecular products derived from proteins
    • C08H1/06—Macromolecular products derived from proteins derived from horn, hoofs, hair, skin or leather
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00365—Plasters use
    • A61F2013/00463—Plasters use haemostatic
    • A61F2013/00472—Plasters use haemostatic with chemical means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
TW091101272A 2001-01-25 2002-01-25 A suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge TWI255726B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100135 2001-01-25
DKPA200100235 2001-02-13

Publications (1)

Publication Number Publication Date
TWI255726B true TWI255726B (en) 2006-06-01

Family

ID=26068956

Family Applications (2)

Application Number Title Priority Date Filing Date
TW091101272A TWI255726B (en) 2001-01-25 2002-01-25 A suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge
TW091101277A TWI237573B (en) 2001-01-25 2002-01-25 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW091101277A TWI237573B (en) 2001-01-25 2002-01-25 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge

Country Status (37)

Country Link
EP (4) EP1368419B1 (zh)
JP (4) JP4104462B2 (zh)
KR (2) KR100847417B1 (zh)
CN (3) CN1290907C (zh)
AR (3) AR032517A1 (zh)
AT (2) ATE310044T1 (zh)
AU (3) AU2002255220B2 (zh)
BG (3) BG66439B1 (zh)
BR (3) BRPI0206708B8 (zh)
CA (3) CA2435159C (zh)
CL (1) CL2015003111A1 (zh)
CR (1) CR7034A (zh)
CZ (3) CZ305120B6 (zh)
DE (2) DE60207389T2 (zh)
DK (2) DK1368419T3 (zh)
EA (4) EA006686B1 (zh)
EE (3) EE05587B1 (zh)
EG (2) EG26417A (zh)
ES (2) ES2238569T3 (zh)
HK (2) HK1058319A1 (zh)
HR (1) HRP20030648B1 (zh)
HU (3) HU228810B1 (zh)
IL (6) IL157096A0 (zh)
IS (1) IS6885A (zh)
ME (1) ME00587B (zh)
MX (3) MXPA03006687A (zh)
NO (3) NO332462B1 (zh)
NZ (3) NZ527165A (zh)
PL (3) PL206194B1 (zh)
PT (1) PT1343542E (zh)
RS (1) RS50866B (zh)
SI (2) SI1343542T1 (zh)
SK (3) SK10342003A3 (zh)
TW (2) TWI255726B (zh)
UA (1) UA73028C2 (zh)
UY (1) UY27136A1 (zh)
WO (3) WO2002058750A2 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI552774B (zh) * 2011-05-24 2016-10-11 武田公司 經輥軋之膠原蛋白載體

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131933A1 (en) * 1996-01-16 2002-09-19 Yves Delmotte Biopolymer membrane and methods for its preparation
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7279177B2 (en) 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
US7252837B2 (en) 2002-06-28 2007-08-07 Ethicon, Inc. Hemostatic wound dressing and method of making same
US20040131771A1 (en) * 2002-11-04 2004-07-08 Poul Egon Bertelsen Coating of particulate material with organic based coating composition for the preparation of drug delivery systems
WO2004064878A1 (ja) * 2003-01-20 2004-08-05 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 止血用材料
AU2004226578A1 (en) 2003-04-04 2004-10-14 Tissuemed Limited Tissue-adhesive formulations
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US20040265371A1 (en) 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US7186684B2 (en) * 2003-08-07 2007-03-06 Ethicon, Inc. Hemostatic device containing a protein precipitate
AU2005268647B2 (en) 2004-08-03 2011-04-14 Tissuemed Limited Tissue-adhesive materials
DK1809343T3 (da) 2004-10-20 2012-11-26 Ethicon Inc Forstærket absorberbar hæmostatisk flerlagssårforbinding samt fremstillingsfremgangsmåde
BRPI0516220B8 (pt) 2004-10-20 2021-06-22 Ethicon Inc tecido de multicamadas absorvíveis reforçadas para aplicação em dispositivos médicos e método de fabricação
US9358318B2 (en) 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
KR20060040329A (ko) * 2004-11-05 2006-05-10 나건 내시경을 통하여 도포 가능한 체내 지혈제 및 그 도포 방법
AU2006241123B2 (en) 2005-04-25 2013-10-03 Massachusetts Institute Of Technology Compositions and methods for promoting hemostasis and other physiological activities
JP4864348B2 (ja) * 2005-05-27 2012-02-01 川澄化学工業株式会社 神経再生チューブ
CA2640629A1 (en) 2006-02-03 2007-08-09 Tissuemed Limited Tissue-adhesive materials
EP1986709B8 (en) 2006-02-14 2017-10-18 Cook Medical Technologies LLC Joining and/or sealing tissues through photo-activated cross-linking of matrix proteins
DK2012842T3 (en) 2006-04-25 2018-05-28 Massachusetts Inst Technology COMPOSITIONS AND PROCEDURES TO INFLUENCE THE MOVEMENT OF CONTAMINANTS, BODIES, OR OTHER UNITS AND / OR TO INFLUENCE OTHER PHYSIOLOGICAL CONDITIONS
WO2007137839A2 (en) 2006-05-31 2007-12-06 Baxter International Inc. Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
TWI436793B (zh) 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
US8445009B2 (en) * 2006-08-04 2013-05-21 Stb, Ltd Processes for the production of solid dressings for treating wounded tissue
GB0623607D0 (en) * 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
CN101053679B (zh) * 2007-04-17 2010-05-26 浙江大学 一种纤维蛋白凝胶填充的聚合物多孔支架的制备方法
DE102007037056A1 (de) 2007-07-24 2009-01-29 Aesculap Ag Hämostyptikum
DE102007037053A1 (de) 2007-07-24 2009-01-29 Aesculap Ag Hämostyptikum für die minimal-invasive Operation
DE102007045066A1 (de) 2007-09-20 2009-04-02 Mike Ehrlich Material zur Blutstillung enthaltend synthetische Peptide oder Polysaccharide
DE102007000574A1 (de) 2007-10-25 2009-04-30 FILK Forschungsinstitut für Leder- und Kunstbahnen gGmbH Biologisch resorbierbares Schwammmaterial und Verfahren zu dessen Herstellung
US8790698B2 (en) 2007-10-30 2014-07-29 Baxter International Inc. Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
CN101214391B (zh) * 2007-12-27 2010-05-19 广州倍绣生物技术有限公司 一种高效生物胶封闭剂及其应用
EP2259803B2 (en) 2008-02-29 2019-03-13 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
WO2010002435A2 (en) * 2008-07-03 2010-01-07 Kulinets Irina B Hemostatic pouch and method to stabilize hemostatic components
CN102170919A (zh) 2008-10-06 2011-08-31 三维肽胶株式会社 组织闭塞剂
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
MX2011013795A (es) 2009-06-16 2012-04-30 Baxter Int Esponja hemostatica.
US9271925B2 (en) 2013-03-11 2016-03-01 Bioinspire Technologies, Inc. Multi-layer biodegradable device having adjustable drug release profile
WO2011035020A1 (en) 2009-09-18 2011-03-24 Bioinspire Technologies, Inc. Free-standing biodegradable patch
US9439941B2 (en) 2009-12-14 2016-09-13 The University Of Hong Kong Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells
EP2512535A1 (en) 2009-12-16 2012-10-24 Baxter International Inc Hemostatic sponge
AU2011210356B2 (en) 2010-01-28 2015-05-28 Omrix Biopharmaceuticals Ltd. Method for improved fibrin sealing
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
CN103037847B (zh) 2010-06-01 2016-01-20 巴克斯特国际公司 用于制备干燥、稳定的止血组合物的方法
AU2011260274B2 (en) 2010-06-01 2015-07-02 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
MX345479B (es) 2010-06-01 2017-02-01 Baxter Int Inc * Proceso para elaborar composiciones hemostaticas secas y estables.
KR101865160B1 (ko) 2010-07-20 2018-06-07 잇빤 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 조직 접착용 시트 제제
RU2013155713A (ru) * 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран
CN102357259A (zh) 2011-07-28 2012-02-22 王珊珊 一种生物蛋白海绵及其制备方法
US20130041406A1 (en) * 2011-08-10 2013-02-14 Brian W. Bear Surgical staple with localized adjunct coating
EP2556842A1 (en) 2011-08-11 2013-02-13 Bioftalmik, S.L. Composition in the form of film comprising fibrinogen and a fibrinogen activator and the applications thereof
WO2013053755A2 (en) 2011-10-11 2013-04-18 Baxter International Inc. Hemostatic compositions
JP6195569B2 (ja) 2011-10-11 2017-09-13 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 止血組成物
UY34414A (es) 2011-10-27 2013-04-30 Baxter Int Composiciones hemostáticas
US11109849B2 (en) 2012-03-06 2021-09-07 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
KR102259117B1 (ko) 2012-05-14 2021-05-31 데이진 가부시키가이샤 시트 성형체 및 지혈재
JP6242874B2 (ja) * 2012-05-24 2017-12-06 タケダ エイエスＴａｋｅｄａ ＡＳ パッケージ
US10213345B2 (en) 2012-05-24 2019-02-26 Takeda As Apparatus and process for providing a coiled collagen carrier
EP2977066A3 (en) 2012-06-12 2016-07-27 Ferrosan Medical Devices A/S Dry haemostatic composition
CN104902974B (zh) 2012-07-06 2017-07-28 三维矩阵有限公司 肽溶液的灌装加工法
DE102013004420A1 (de) 2012-08-20 2014-02-20 Alexander Kopp Stützkörper und Verfahren zu seiner Herstellung
CN104902935B (zh) * 2012-12-07 2017-11-24 巴克斯特国际公司 止血泡沫
KR101401944B1 (ko) 2012-12-11 2014-05-30 세원셀론텍(주) 콜라겐과 피브린이 혼합된 조직 실란트 및 그 제조방법
US9724078B2 (en) 2013-06-21 2017-08-08 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US10765774B2 (en) 2013-07-09 2020-09-08 Ethicon, Inc. Hemostatic pad assembly kit and method
US10111980B2 (en) 2013-12-11 2018-10-30 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
CN117138022A (zh) 2014-03-10 2023-12-01 三维矩阵有限责任公司 自组装肽组合物
ES2712608T3 (es) 2014-03-10 2019-05-14 3 D Matrix Ltd Péptidos autoensamblantes para el tratamiento de las bullas pulmonares
EP3628337A1 (en) 2014-03-10 2020-04-01 3-D Matrix, Ltd. Sterilization and filtration of peptide compositions
CN106999621B (zh) 2014-10-13 2020-07-03 弗罗桑医疗设备公司 用于止血和伤口愈合的干组合物
WO2016102446A1 (en) 2014-12-24 2016-06-30 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
US10918796B2 (en) 2015-07-03 2021-02-16 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
CN106267328B (zh) * 2016-09-20 2019-04-12 安徽思维特生物科技有限公司 一种聚己内酯-胎牛皮胶原纤维复合止血凝胶的制备方法
CN106730031A (zh) * 2016-12-30 2017-05-31 清华大学 一种用于脊髓损伤修复的仿生纤维蛋白水凝胶束及其制备方法
US11324703B2 (en) 2017-12-15 2022-05-10 3-D Matrix, Ltd. Surfactant peptide nanostructures and uses thereof in drug delivery
AU2019266529B2 (en) 2018-05-09 2024-05-23 Ethicon Inc. Method for preparing a haemostatic composition
RU2679616C1 (ru) * 2018-07-02 2019-02-12 Государственное бюджетное учреждение здравоохранения города Москвы Научно-исследовательский институт скорой помощи имени Н.В. Склифосовского Департамента здравоохранения г. Москвы Способ приготовления тромбофибринового сгустка, обладающего ростстимулирующими свойствами
US20220016311A1 (en) * 2018-12-14 2022-01-20 Bmg Incorporated Two-reactant sheet-shaped adhesive/reinforcement for tissues
CN112225937B (zh) * 2020-10-14 2022-11-01 中山大学 一种温敏型大孔生物水凝胶及其制备方法和应用
CN113117158B (zh) * 2021-03-10 2022-07-26 复旦大学 表面变性蛋白生物功能化修饰的材料及其制备方法和应用
CN114246974B (zh) * 2021-12-24 2023-11-03 中国人民解放军军事科学院军事医学研究院 一种止血贴的制备方法
CN114177346B (zh) * 2021-12-24 2023-05-26 中国人民解放军军事科学院军事医学研究院 一种止血组合物及止血贴与其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1596789A (zh) * 1968-11-27 1970-06-22
DE3105624A1 (de) * 1981-02-16 1982-09-02 Hormon-Chemie München GmbH, 8000 München Material zum abdichten und heilen von wunden
BR8102435A (pt) * 1981-04-15 1982-11-30 Campos Vidal Benedicto Colageno i microfibrilar e microcristalino para aplicacao em medicina e farmacia
DE3214337C2 (de) * 1982-04-19 1984-04-26 Serapharm - Michael Stroetmann, 4400 Münster Resorbierbares Flachmaterial zum Abdichten und Heilen von Wunden und Verfahren zu dessen Herstellung
US4626286A (en) 1983-10-31 1986-12-02 Schmid Laboratories, Inc. Collagen gel and the process of making said gel
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
FR2668936B1 (fr) * 1990-11-09 1993-01-15 Eberlin Jean Luc Greffon a base de collagene et de colle de fibrine pour la reconstruction osteo-cartilagineuse et son procede de preparation.
WO1992017209A1 (en) * 1991-04-08 1992-10-15 Sumitomo Pharmaceuticals Company, Limited Porous solid preparation containing physiologically active protein substance
AT410754B (de) * 1993-03-31 2003-07-25 Nycomed Austria Gmbh Vorrichtung zum gleichmässigen auftragen einer suspension auf einen kollagenträger
US6177126B1 (en) * 1993-03-31 2001-01-23 Nycomed Arzneimittel Gmbh Process for the production of a material for sealing and healing wounds
JPH0759812A (ja) * 1993-08-27 1995-03-07 Koken Co Ltd 創傷カバ−材及びその製造方法
WO1996007728A1 (en) * 1994-09-02 1996-03-14 New York Blood Center, Inc. Production and secretion of recombinant fibrinogen by yeast
CA2245585A1 (en) * 1996-02-06 1997-08-14 David P. Kosow Composition for sealing wounds
ATE247494T1 (de) * 1996-04-04 2003-09-15 Baxter Ag Blutstillender schwamm auf kollagenbasis
DE69906047T2 (de) * 1998-05-01 2003-10-16 Zymogenetics, Inc. Vollständig rekombinanter gewebekleber
ATE254934T1 (de) * 1998-05-19 2003-12-15 American Nat Red Cross Blutstillende mehrschichtige bandage, die eine thrombinschicht zwischen zwei fibrinogenschichten enthält
CA2339575A1 (en) * 1998-08-10 2000-02-24 James W. Polarek Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
ATE222781T1 (de) * 1998-12-23 2002-09-15 Aventis Behring Gmbh Fibrinklebergranulat und verfahren zu dessen herstellung
DE19922078A1 (de) * 1999-05-15 2000-11-23 Weitzel Kage Doris Gewebekonstrukt für die Transplantationschirurgie

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI552774B (zh) * 2011-05-24 2016-10-11 武田公司 經輥軋之膠原蛋白載體

Also Published As

Publication number Publication date
BG108123A (bg) 2004-09-30
DE60207389D1 (de) 2005-12-22
HUP0303893A3 (en) 2012-02-28
IL157095A (en) 2009-06-15
BR0206705B1 (pt) 2012-08-07
CZ20032199A3 (cs) 2003-12-17
BG66439B1 (bg) 2014-08-29
AR032400A1 (es) 2003-11-05
UA73028C2 (uk) 2005-05-16
JP4535678B2 (ja) 2010-09-01
JP2007190399A (ja) 2007-08-02
BRPI0206708B8 (pt) 2021-06-22
NZ527167A (en) 2005-02-25
NO20033295D0 (no) 2003-07-22
BG108121A (bg) 2004-08-31
CN1246047C (zh) 2006-03-22
KR100847417B1 (ko) 2008-07-18
CZ305120B6 (cs) 2015-05-13
WO2002058750A3 (en) 2002-10-31
WO2002070594A3 (en) 2003-01-03
EE05685B1 (et) 2013-12-16
NO20033296D0 (no) 2003-07-22
NO20033296L (no) 2003-09-25
HUP0303896A2 (hu) 2004-03-01
CN1487967A (zh) 2004-04-07
CZ304357B6 (cs) 2014-03-26
BR0206709A (pt) 2004-02-17
HU228810B1 (hu) 2013-05-28
CN1290907C (zh) 2006-12-20
ATE310044T1 (de) 2005-12-15
KR20030085522A (ko) 2003-11-05
IL157097A0 (en) 2004-02-08
CR7034A (es) 2004-03-05
BG66420B1 (bg) 2014-03-31
CA2434964C (en) 2009-04-21
EE05678B1 (et) 2013-10-15
ES2238569T3 (es) 2005-09-01
WO2002058750A2 (en) 2002-08-01
HUP0400768A3 (en) 2006-01-30
HK1058371A1 (en) 2004-05-14
JP4104462B2 (ja) 2008-06-18
IL157096A0 (en) 2004-02-08
TWI237573B (en) 2005-08-11
JP2005502733A (ja) 2005-01-27
DE60207389T2 (de) 2006-08-03
SK10342003A3 (sk) 2004-02-03
NO327386B1 (no) 2009-06-22
CA2435159C (en) 2009-07-28
UY27136A1 (es) 2002-09-30
PL363274A1 (en) 2004-11-15
EA200401463A1 (ru) 2005-08-25
MXPA03006689A (es) 2004-03-12
CA2435159A1 (en) 2002-09-12
NO20033295L (no) 2003-09-25
KR20030086254A (ko) 2003-11-07
SI1343542T1 (en) 2005-10-31
EA006686B1 (ru) 2006-02-24
CZ20032198A3 (cs) 2003-12-17
SK10362003A3 (sk) 2004-03-02
EE200300341A (et) 2003-10-15
IL157095A0 (en) 2004-02-08
BR0206708A (pt) 2004-02-25
RS50866B (sr) 2010-08-31
PT1343542E (pt) 2005-08-31
BG66343B1 (bg) 2013-07-31
DK1368419T3 (da) 2006-04-03
MXPA03006688A (es) 2004-03-12
SK10352003A3 (sk) 2004-02-03
JP2004520124A (ja) 2004-07-08
HRP20030648B1 (en) 2011-10-31
WO2002058749A8 (en) 2004-03-11
NO332462B1 (no) 2012-09-24
IS6885A (is) 2003-07-24
HU227987B1 (hu) 2012-07-30
AU2002307809B2 (en) 2007-10-04
CZ20032197A3 (cs) 2003-11-12
DE60203364D1 (de) 2005-04-28
EP1359947A2 (en) 2003-11-12
JP2004521115A (ja) 2004-07-15
ME00587A (en) 2011-12-20
HUP0303893A2 (hu) 2004-03-01
HK1058319A1 (en) 2004-05-14
WO2002070594A8 (en) 2004-03-11
BRPI0206709B1 (pt) 2015-09-08
PL363275A1 (en) 2004-11-15
BG108122A (bg) 2004-09-30
NO20033297L (no) 2003-09-25
EG24589A (en) 2009-12-01
EA200300823A1 (ru) 2004-04-29
EP1368419B1 (en) 2005-11-16
CN1264578C (zh) 2006-07-19
WO2002058749A2 (en) 2002-08-01
CA2435425A1 (en) 2002-08-01
EE200300348A (et) 2003-10-15
EP1547626A3 (en) 2009-07-29
ES2253523T3 (es) 2006-06-01
EE200300349A (et) 2003-10-15
EA200300822A1 (ru) 2004-02-26
AU2002255220B2 (en) 2007-05-31
WO2002058749A3 (en) 2002-10-10
CA2435425C (en) 2010-07-27
SK287874B6 (sk) 2012-02-03
HRP20030648A2 (en) 2005-06-30
EP1343542B1 (en) 2005-03-23
AR032800A1 (es) 2003-11-26
BRPI0206709B8 (pt) 2021-06-22
DK1343542T3 (da) 2005-07-25
PL206194B1 (pl) 2010-07-30
CN1487843A (zh) 2004-04-07
BR0206705A (pt) 2004-02-25
YU67003A (sh) 2006-05-25
WO2002058750A8 (en) 2004-03-11
DE60203364T2 (de) 2005-09-01
CN1507358A (zh) 2004-06-23
EP1547626A2 (en) 2005-06-29
CL2015003111A1 (es) 2016-07-08
IL157097A (en) 2009-12-24
IL157096A (en) 2007-08-19
NZ527166A (en) 2005-03-24
HUP0303896A3 (en) 2005-12-28
SK288120B6 (sk) 2013-09-03
EG26417A (en) 2013-10-22
PL366932A1 (en) 2005-02-07
CA2434964A1 (en) 2002-08-01
EA005697B1 (ru) 2005-04-28
BRPI0206705B8 (pt) 2021-07-27
AU2002249528B2 (en) 2007-03-29
KR100830294B1 (ko) 2008-05-16
BRPI0206708B1 (pt) 2015-07-14
EA006700B1 (ru) 2006-02-24
EP1343542A2 (en) 2003-09-17
ATE291445T1 (de) 2005-04-15
WO2002070594A2 (en) 2002-09-12
EA006540B1 (ru) 2006-02-24
NZ527165A (en) 2005-02-25
EA200300821A1 (ru) 2004-04-29
PL205181B1 (pl) 2010-03-31
PL206197B1 (pl) 2010-07-30
SI1368419T1 (sl) 2006-06-30
NO20033297D0 (no) 2003-07-22
HUP0400768A2 (hu) 2004-07-28
EE05587B1 (et) 2012-10-15
ME00587B (me) 2011-12-20
MXPA03006687A (es) 2004-03-12
AR032517A1 (es) 2003-11-12
EP1368419A2 (en) 2003-12-10

Similar Documents

Publication Publication Date Title
TWI255726B (en) A suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge
NO20002357D0 (no) Fibrin tetningsmasse eller lim omfattende et hyaluronsyrederivat materiale
CA2295247A1 (en) Compositions containing thrombin and microfibrillar collagen
GB2348426A (en) Enzyme-mediated modification of fibrin for tissue engineering
AU2511101A (en) A process for preparing an autologous platelet gel and membranes thereof, and a kit for carrying out this process
AU1941197A (en) Tissue adhesive suitable for spray application
DE50005818D1 (de) Spritzbares knochenersatzmaterial enthaltend fibrin oder fibrinogen sowie hydroxylapatit zement
ATE413182T1 (de) Gerät und verfahren zur herstellung von stabilem langzeitigem thrombin aus plasma sowie so hergestelltes thrombin
MX9603285A (es) Concentrado de plasma y composiciones obturadoras de tejido y metodos y aparatos para preparar el concentrado de plasma y/o el obturador de tejido para sellar el tejido, para la separacion rapida de particulas de suspensiones y para la concentracion
WO2003057072A8 (en) Hemostatic compositions and methods for controlling bleeding
DE60219775D1 (de) Als bindemittel dienende enzympräparate sowie verfahren zur herstellung von gebundenen, geformten nahrungsmitteln
DE69906047D1 (de) Vollständig rekombinanter gewebekleber
Marx et al. Characterizing fibrin glue performance as modulated by heparin, aprotinin, and factor XIII
DE69422165D1 (de) Zweikomponenten-fibrinkleber
WO2004028465A3 (en) Hemostatic compositions and methods
JP7225313B2 (ja) シーラント配合物
ATE283714T1 (de) Preadipozyten enthaltende biomaterialien zur regeneration von weichgewebe
BR9810242A (pt) Composições úteis como selante de fibrina
UY27139A1 (es) Una suspensión que comprende fibrinogeno, trombina y alcohol, un procedimiento para preparar dicha suspensión, un procedimiento para recubrir un soporte con dicha suspensión, un procedimiento de secado de un recubrimiento de un soporte, y una esponja
MXPA04004304A (es) Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos del factor v.

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees